Innovative Eyewear Gets Nasdaq Bid-Price Deficiency Notice; 180 Days to April 7, 2027
LUCY sits 30% above its 52-week low of $0.65.
Summary
Innovative Eyewear received a Nasdaq minimum bid price deficiency notice on October 9, giving it until April 7, 2027 to trade above $1.00 for 10 consecutive days. The cure path runs through the reverse split already set for a November 16 shareholder vote.
Key Events · Legal and Risk Events · LUCY
-
Nasdaq Bid-Price Deficiency Notice
On October 9, 2026, Nasdaq notified the company that its common stock closed below $1.00 for 30 consecutive business days, failing Listing Rule 5550(a)(2). The notice has no immediate effect on the listing.
-
180-Day Cure Window to April 7, 2027
The company must hold a closing bid of at least $1.00 for 10 consecutive business days by April 7, 2027. A second 180-day period is possible only if it meets initial listing criteria and commits to a reverse split if needed.
-
Reverse Split Vote Set for November 16
The definitive proxy filed October 5 sets a November 16 shareholder vote on a reverse split between 1-for-2 and 1-for-12 — the primary tool available to cure the bid-price deficiency.
-
Prior Control Weaknesses and Cash Burn
The Q2 10-Q filed August 14 disclosed material weaknesses in internal controls and significant cash burn, alongside 74% revenue growth and a return to positive gross margin.
Analysis · LUCY · Industrial Applications And Services
Nasdaq notified Innovative Eyewear on October 9 that its common stock closed below $1.00 for 30 consecutive business days, breaching Listing Rule 5550(a)(2). The company has until April 7, 2027 to get the closing bid back to at least $1.00 for 10 straight business days, with a possible second 180-day window if it meets initial listing criteria and commits to a reverse split. This is the first public disclosure of the deficiency, and it lands squarely on top of the reverse split already scheduled for a November 16 shareholder vote — the proxy ranges from 1-for-2 to 1-for-12. The notice itself does not suspend trading, but it makes the reverse split the near-certain mechanism for keeping the listing, and it comes after a Q2 10-Q that already flagged material weaknesses in internal controls and significant cash burn. If the split is approved and executed, the bid-price cure is largely mechanical; if shareholders reject it, the company is left with a shrinking set of options before the April deadline.
How filings like this one have moved
In the 30 days to Oct 30, 2026, 38.3% of the 896 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LUCY was trading at $0.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.65 to $2.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.